Cell therapy (also called cellular therapy, cell transplantation, or cytotherapy) is a therapy in which viable cells are injected, grafted or implanted into a patient in order to effectuate a medicinal effect, for example, by transplanting T-cells capable of fighting cancer cells via cell-mediated immunity in the course of immunotherapy, or grafting stem cells to regenerate diseased tissues.

Erythropoietin (EPO) is a hormone produced mainly by the kidneys that regulates the production of red blood cells in the body.

Etanercept is a biologic response modifier medication commonly used to treat autoimmune diseases such as rheumatoid arthritis, psoriasis, and ankylosing spondylitis.

The European Medicines Agency (EMA) is an agency of the European Union (EU) in charge of the evaluation and supervision of pharmaceutical products.

Filgrastim, sold under the brand name Neupogen among others, is a medication used to treat low neutrophil count.

A generic drug is a pharmaceutical drug that is equivalent to a brand-name product in dosage form, strength, route of administration, quality, performance characteristics, and intended use, but not in patent protection.

Insulin is a hormone produced by the pancreas that plays a crucial role in regulating blood sugar (glucose) levels in the body.

Insulin aspart, sold under the brand name NovoLog, among others, is a modified type of medical insulin used to treat type 1 and type 2 diabetes.